Nateglinide

STARLIX 180 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

180 mg comprimido recubierto con películaSpainWithdrawnAuthorised 2 May 2001

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

StarlixBrazil · Novartis Biociencias S.ASame brand
Starlix 120MGCanada · 120 MG · Tablet · Novartis Pharmaceuticals Canada INCSame brand
Starlix 180MGCanada · 180 MG · Tablet · Novartis Pharmaceuticals Canada INCSame brand
Starlix 60MGCanada · 60 MG · Tablet · Novartis Pharmaceuticals Canada INCSame brand
StarlixEuropean Union · Novartis Europharm LimitedSame brand
StarlixUnited States · 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · tablet · Novartis

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Nateglinide

STARLIX 180 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

180 mg comprimido recubierto con películaSpainWithdrawnAuthorised 2 May 2001

Product informationAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

NateglinideUnited States · 120MG, 60MG · tablet · Rising

TrazecEuropean Union · Novartis Europharm Ltd.

Packs

Pack	Code	Status
STARLIX 180 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 84 comprimidos	752477

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Nateglinide
Strength: 180 mg
Dosage form: comprimido recubierto con película
Route: vía oral
Register: Spain (AEMPS)
Status: Withdrawn
Status in the register: Revocado
Authorised: 2 May 2001
Registration: 01174019
Marketing authorisation holder: Novartis Europharm Limited
Procedure: EU centralised
Supply: Medicamento Sujeto A Prescripción Médica

SpainWithdrawn